Farzana Khan Shoma, Z. Chowdhury, F. Hossain, Abul Khair Mohammad Salek, M. Khasru, Md. Nuruzzaman Khandaker
{"title":"Intra-articular Injection of Hyaluronic Acid (HA) and Plateletrich Plasma (PRP) in the Treatment of Mild and Moderate Osteoarthritis of Knee","authors":"Farzana Khan Shoma, Z. Chowdhury, F. Hossain, Abul Khair Mohammad Salek, M. Khasru, Md. Nuruzzaman Khandaker","doi":"10.3329/bmrcb.v47i1.55800","DOIUrl":null,"url":null,"abstract":"Background: Osteoarthritis (OA) is the most prevalent chronic joint disorder worldwide and is associated with significant pain and disability. Introduction of platelet-rich plasma (PRP) injection has been viewed as an advance in the management of OA knee.\nObjective: To compare the effectiveness of PRP and Hyaluronic Acid (HA) in the treatment of mild and moderate OA knee\nMethods: The present randomized clinical trial had been conducted in the Department of Physical Medicine and Rehabilitation, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka from 2018 to 2019. A total of 154 patients with mild and moderate OA knee were randomly allocated into two groups: group A (received PRP injection) and group B (received HA injection) where 133 patients completed the follow-up schedule. Outcomes were measured by OA specific translated and validated Bengali instrument- Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaire and visual analogue scale (VAS 0-10). They were followed-up for 6 months.\nResults: There was no significant statistical difference at the baseline between the groups regarding age, sex, grading of OA knee, side involvement, mean duration of the disease, VAS scores and WOMAC scores. After one month, VAS score significantly decreased in PRP group compared to HA group (p<0.001). However, there was no statistical difference regarding total WOMAC scores between two groups (p=0.063). In third and sixth month, VAS score significantly decreased in PRP group compared to HA group (p<0.001). Though the stiffness and physical activity scores of WOMAC did not reduce significantly, the pain score reduced significantly in PRP group compared to HA group. In both groups, significant reduction of VAS and WOMAC total scores was observed after six months follow-up compared to baseline values (p<0.001).\nConclusion: Intra-articular platelet-rich plasma improves pain and function of the knee in patients with osteoarthritis. Though intra-articular hyaluronic acid also improves pain and function in the foot, PRP is more effective than hyaluronic acid. Multi-centered clinical trial with long term follow-up should be conducted to see the effects of PRP and HA.\nBangladesh Med Res Counc Bull 2021; 47(1): 62-69","PeriodicalId":8704,"journal":{"name":"Bangladesh Medical Research Council Bulletin","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bangladesh Medical Research Council Bulletin","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3329/bmrcb.v47i1.55800","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1
Abstract
Background: Osteoarthritis (OA) is the most prevalent chronic joint disorder worldwide and is associated with significant pain and disability. Introduction of platelet-rich plasma (PRP) injection has been viewed as an advance in the management of OA knee.
Objective: To compare the effectiveness of PRP and Hyaluronic Acid (HA) in the treatment of mild and moderate OA knee
Methods: The present randomized clinical trial had been conducted in the Department of Physical Medicine and Rehabilitation, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka from 2018 to 2019. A total of 154 patients with mild and moderate OA knee were randomly allocated into two groups: group A (received PRP injection) and group B (received HA injection) where 133 patients completed the follow-up schedule. Outcomes were measured by OA specific translated and validated Bengali instrument- Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaire and visual analogue scale (VAS 0-10). They were followed-up for 6 months.
Results: There was no significant statistical difference at the baseline between the groups regarding age, sex, grading of OA knee, side involvement, mean duration of the disease, VAS scores and WOMAC scores. After one month, VAS score significantly decreased in PRP group compared to HA group (p<0.001). However, there was no statistical difference regarding total WOMAC scores between two groups (p=0.063). In third and sixth month, VAS score significantly decreased in PRP group compared to HA group (p<0.001). Though the stiffness and physical activity scores of WOMAC did not reduce significantly, the pain score reduced significantly in PRP group compared to HA group. In both groups, significant reduction of VAS and WOMAC total scores was observed after six months follow-up compared to baseline values (p<0.001).
Conclusion: Intra-articular platelet-rich plasma improves pain and function of the knee in patients with osteoarthritis. Though intra-articular hyaluronic acid also improves pain and function in the foot, PRP is more effective than hyaluronic acid. Multi-centered clinical trial with long term follow-up should be conducted to see the effects of PRP and HA.
Bangladesh Med Res Counc Bull 2021; 47(1): 62-69
背景:骨关节炎(OA)是世界上最常见的慢性关节疾病,与严重的疼痛和残疾有关。富血小板血浆(PRP)注射被认为是膝关节骨性关节炎治疗的一个进步。目的:比较PRP和透明质酸(HA)治疗轻度和中度OA膝关节的有效性方法:本随机临床试验于2018年至2019年在达卡Bangabandhu Sheikh Mujib医科大学(BSMMU)物理医学与康复系进行。共有154名轻度和中度膝关节骨性关节炎患者被随机分为两组:A组(接受PRP注射)和B组(接受HA注射),其中133名患者完成了随访计划。通过OA特异性翻译和验证的孟加拉语仪器-西安大略大学和麦克马斯特大学骨关节炎指数(WOMAC)问卷和视觉模拟量表(VAS 0-10)测量结果。随访6个月。结果:在基线时,两组在年龄、性别、OA膝关节分级、侧面受累、疾病平均持续时间、VAS评分和WOMAC评分方面没有显著的统计学差异。一个月后,与HA组相比,PRP组的VAS评分显著降低(p<0.001)。然而,两组之间的WOMAC总分没有统计学差异(p=0.063)。在第三个月和第六个月,PRP小组的VAS评分与HA组比较显著降低(p<0.001),尽管WOMAC的僵硬和体力活动评分没有显著降低,与HA组相比,PRP组的疼痛评分显著降低。与基线值相比,两组患者在随访6个月后VAS和WOMAC总分均显著降低(p<0.001)。结论:关节内富含血小板的血浆可改善骨关节炎患者的膝盖疼痛和功能。尽管关节内透明质酸也能改善足部疼痛和功能,但PRP比透明质酸更有效。应进行长期随访的多中心临床试验,以观察PRP和HA的效果。Bangladesh Med Res Counc Bull 2021;47(1):62-69